BPCA Funding Mechanisms

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) will issue funding mechanisms to offerors capable of conducting studies to gather pediatric use information. NICHD utilizes the information contained in the Proposed Pediatric Study Request (PPSR) or the Written Request (WR) which have been referred from FDA for specific drugs (and indications).

The resultant contracts/grants are awarded to entities that have expertise in conducting pediatric clinical trials, including:

• Qualified universities, hospitals, and Contract Research Organizations (CROs)
• Federally funded networks (such as the Pediatric Pharmacology Research Unit Network, the Neonatal Research Network, and the Maternal Fetal Medicine Units Network)
• Other public or private institutions.

Lead clinical centers, which subcontract to other clinical sites; pediatric clinical trials networks; CROs; and single academic centers are all eligible for funding depending on the overall qualifications, experience in pediatric drug trials, type of drug under study, specific drug indication, and access to target pediatric populations. It is expected that most studies will involve multiple sites. Established pediatric drug trials networks or offerors that have access to multiple sites will be encouraged to apply.

BPCA Requests for Proposals (RFPs) in the Federal Business Opportunities

Find "Federal Business Opportunities" at FedBizOpps

The NIH Guide for Grants and Contracts is the official publication for NIH medical and behavioral research grant policies, guidelines and funding opportunities.

http://grants.nih.gov/grants/guide/index.html